2XG-38817-20916
1 vaccination
1 coded response
8 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 430 / OH
- Registered
- 2021-01-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-15
Dose 1 — Pfizer-BioNTech
-
2021-01-18
Registered in v-safe
- 2021-01-18
- 2021-01-19
- 2021-01-21
- 2021-01-22
- 2021-01-29
- 2021-02-05
-
2021-04-16
Survey response — 3 months, dose 1MedDRA: Dermatitis, Office visit — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Interface dermatitis on both thighs and legs · Healthcare visit (other): DermatologistMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-16
Report sent to call center — 3 months, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-15 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-16 | Unsuccessful |
Free text
Release 7 — 3 months, dose 1
Symptoms: Interface dermatitis on both thighs and legs
Healthcare visit (other): Dermatologist
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Dermatitis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release